Clinic
Marillac Community Health Centers
Marillac Community Health Centers was paid $3.64M by Medicaid between Jan 2018 and Nov 2024, across 82 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 100% of everything it billed.
33Billing provider infoMARILLAC COMMUNITY HEALTH CENTERS
NEW ORLEANS, LA 70113
NEW ORLEANS, LA 70113
33aNPI1457701575assigned 06/20/2016
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$3.64M
24GClaims130,528
24DCodes billed82
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in Louisiana
Rank by total paid#48 of 272
Median peer was paid$574K
This provider vs. median6.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 41,814 | $590K | |
| 2019 | 19,933 | $682K | |
| 2020 | 13,428 | $493K | |
| 2021 | 12,883 | $564K | |
| 2022 | 13,068 | $545K | |
| 2023 | 23,328 | $581K | |
| 2024incomplete | 6,074 | $183K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 100% | 39,297 | 25,298 | $3.64M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 3,613 | 2,468 | $152.81 |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 15,019 | 10,113 | $99.68 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 9,900 | 6,608 | $44.10 |
| 0072A | <1% | 122 | 28 | $36.78 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 7,948 | 4,623 | $27.39 |
| 92551 | <1% | 3,519 | 1,780 | $15.82 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 3,300 | 2,329 | $2.77 |
| 81002 | <1% | 1,668 | 880 | $2.54 | |
| 99173 | <1% | 5,679 | 2,848 | $1.91 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 0% | 4,926 | 3,284 | $0.00 |
| 90648 | 0% | 458 | 320 | $0.00 |
70 more codes
| 90670 | 0% | 2,463 | $0.00 | |
| 86318 | 0% | 643 | $0.00 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 2,214 | $0.00 |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 0% | 4,717 | $0.00 |
| 90649 | 0% | 481 | $0.00 | |
| 1160F | 0% | 3,327 | $0.00 | |
| 90633 | 0% | 1,527 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 506 | $0.00 |
| 99382 | 0% | 45 | $0.00 | |
| 90658 | 0% | 308 | $0.00 | |
| 90473 | 0% | 424 | $0.00 | |
| 81025 | 0% | 34 | $0.00 | |
| 90734 | 0% | 761 | $0.00 | |
| 90715 | 0% | 190 | $0.00 | |
| 83655 | 0% | 388 | $0.00 | |
| 96160 | 0% | 304 | $0.00 | |
| 90710 | 0% | 289 | $0.00 | |
| 90707 | 0% | 149 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 212 | $0.00 |
| 0071A | 0% | 72 | $0.00 | |
| 90671 | 0% | 48 | $0.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 16 | $0.00 |
| 86703 | 0% | 384 | $0.00 | |
| 90700 | 0% | 27 | $0.00 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 46 | $0.00 |
| 90749 | 0% | 118 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 14 | $0.00 |
| 1039F | 0% | 93 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 36 | $0.00 |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 33 | $0.00 |
| 1159F | 0% | 19 | $0.00 | |
| 90680 | 0% | 920 | $0.00 | |
| 90697 | 0% | 329 | $0.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 0% | 409 | $0.00 |
| 3008F | 0% | 4,101 | $0.00 | |
| 81099 | 0% | 818 | $0.00 | |
| 90656 | 0% | 291 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 279 | $0.00 |
| 99381 | 0% | 157 | $0.00 | |
| 99343 | 0% | 41 | $0.00 | |
| 87430 | 0% | 387 | $0.00 | |
| 81001 | 0% | 1,418 | $0.00 | |
| 85018 | 0% | 2,419 | $0.00 | |
| 90651 | 0% | 434 | $0.00 | |
| 90696 | 0% | 288 | $0.00 | |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 39 | $0.00 |
| 90474 | 0% | 71 | $0.00 | |
| 87807 | 0% | 111 | $0.00 | |
| 90698 | 0% | 349 | $0.00 | |
| 90620 | 0% | 96 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 0% | 145 | $0.00 |
| 2000F | 0% | 32 | $0.00 | |
| 91307 | 0% | 217 | $0.00 | |
| 90716 | 0% | 59 | $0.00 | |
| 90686 | 0% | 604 | $0.00 | |
| 90744 | 0% | 99 | $0.00 | |
| 90619 | 0% | 152 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 29 | $0.00 |
| 90688 | 0% | 93 | $0.00 | |
| 90677 | 0% | 57 | $0.00 | |
| 4037F | 0% | 298 | $0.00 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 19 | $0.00 |
| 90732 | 0% | 19 | $0.00 | |
| 36416 | 0% | 165 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 79 | $0.00 |
| 90723 | 0% | 96 | $0.00 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 0% | 18 | $0.00 |
| 3351F | 0% | 12 | $0.00 | |
| 99383 | 0% | 20 | $0.00 | |
| 3079F | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialOATIS-GASKEW, TANYELLE (LEAD CREDENTIALING SPECIALIST)
| Provider | Location | Paid |
|---|---|---|
| Marillac Community Health Centers | Harvey, LA | $3.70M |
| Marillac Community Health Centers | New Orleans, LA | $94K |
| Marillac Community Health Centers | Gould, AR | $19K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.